Article info
Letters
Rituximab-treated membranous lupus nephritis: clinical outcome and effects on electron dense deposits
- Correspondence to Dr Thórunn Jónsdóttir, Department of Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, S-171 76 Stockholm, Sweden; thorunn.jonsdottir{at}karolinska.se
Citation
Rituximab-treated membranous lupus nephritis: clinical outcome and effects on electron dense deposits
Publication history
- Accepted September 26, 2010
- First published March 2, 2011.
Online issue publication
October 31, 2019
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions